Hydroxychloroquine ‘Significantly’ Reduces Death Rate From CCP-virus, Detroit area study shows

0
289

Anti-malaria drug hydroxychloroquine helps the lower the death rate of CCP-virus patients according to a study in the Detroit area conducted by Henry Ford Health System.

https://www.detroitnews.com/story/news/local/michigan/2020/07/02/michigan-henry-ford-health-study-finds-hydroxychloroquine-lowers-covid-19-death-rate/5365090002/

Due to a lack of effective alternatives, Chinese and Indian doctors at the frontline fighting the CCP-virus also take hydroxychloroquine to prevent infections.

But it is worth noting that there are studies against the use of hydroxychloroquine for patients in critical condition combined with a high dosage of the drug. But the effective way to use this drug is a low dosage for patients with early symptoms.

June 30: UK Resumes trials on hydroxychloroquine

1
0 Comments
Inline Feedbacks
View all comments